Breaking News Instant updates and real-time market news.

TWOU

2U

$63.27

-0.56 (-0.88%)

07:48
11/06/18
11/06
07:48
11/06/18
07:48

2U should be bought on post-earnings weakness, says Barrington

Barrington analyst Alexander Paris, Jr. noted that 2U shares were sharply lower in after-market trading after the company's preliminary 2019 earnings guidance came in below consensus expectations due to planned increases in marketing expenses. He lowered his price target on 2U shares to $75 from $100 to account for his lower near-term earnings expectations as well as lower valuation multiples overall, but sees the post-earnings selloff as a buying opportunity and keeps an Outperform rating on the stock.

  • 08

    Nov

TWOU 2U
$63.27

-0.56 (-0.88%)

10/24/18
NEED
10/24/18
INITIATION
Target $80
NEED
Buy
2U initiated with a Buy at Needham
Needham analyst Ryan MacDonald initiated 2U with a Buy rating and a price target of $80, citing its offering of a "cloud-based software platform" designed to "bring university partners into the digital age via online graduate degree and short course programs". The analyst expects the company to capture additional market share based on the continued strong demand for online programs and the "continued scaling of the short course segment", anticipating a 30% annual revenue growth through FY20. MacDonald further contends that the graduate program segment opportunity is poised for accelerating growth, adding that the 5.5-times enterprise value to expected FY19 sales valuation multiple of 2U is attractive.
10/24/18
10/24/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Outperform at JMP Securities. 2. Comcast (CMCSA) resumed with a Buy at Deutsche Bank, reinstated with a Buy at Citi, and assumed with a Neutral at Guggenheim. 3. 2U (TWOU) initiated with a Buy at Needham. 4. Corbus Pharmaceuticals (CRBP) initiated with a Buy at B. Riley FBR. 5. Entasis Therapeutics (ETTX) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/06/18
PIPR
11/06/18
NO CHANGE
Target $76
PIPR
Neutral
2U price target lowered to $76 from $94 at Piper Jaffray
Piper Jaffray analyst Peter Appert lowered his price target for 2U to $76 and keeps a Neutral rating on the shares following the company's Q3 results. Lower near-term EBITDA estimates and limited visibility into the timing of an inflection to free cash flow will likely keep the stock "under wraps near-term," Appert tells investors in a post-earnings research note. The analyst reduced his near-term estimates to reflect the company's higher investment spending.
11/06/18
KEYB
11/06/18
NO CHANGE
Target $80
KEYB
Overweight
2U price target lowered to $80 form $100 at KeyBanc
KeyBanc analyst Monika Garg lowered her price target for 2U to $80 from $100 on lower 2019 EV/sales multiple given program specific factors and lower profitability expectations. The analyst notes the company reported modestly better Q3 results, and raised 2018 guidance accordingly. While 2U provided 2019 revenue guidance in line with expectations, it lowered EBITDA to prioritize investments, she points out, adding that 2U indicated academic leadership changes at two early programs were impacting 2019 DGP growth. Garg reiterated an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

FB

Facebook

$143.86

-0.39 (-0.27%)

, PUBGY

Publicis

$0.00

(0.00%)

06:22
11/16/18
11/16
06:22
11/16/18
06:22
Periodicals
Facebook lack of morals drawing ire from advertisers, New York Times reports »

Facebook (FB) is coming…

FB

Facebook

$143.86

-0.39 (-0.27%)

PUBGY

Publicis

$0.00

(0.00%)

WPP

WPP

$55.45

-0.65 (-1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

EVKIF

Evonik

$0.00

(0.00%)

06:20
11/16/18
11/16
06:20
11/16/18
06:20
Downgrade
Evonik rating change  »

Evonik downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

06:16
11/16/18
11/16
06:16
11/16/18
06:16
Periodicals
Volkswagen CEO to assume responsibility for China business, Reuters reports »

Volkswagen CEO Herbert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

06:13
11/16/18
11/16
06:13
11/16/18
06:13
Recommendations
Nvidia analyst commentary  »

Nvidia price target cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

YEXT

Yext

$17.44

0.35 (2.05%)

06:08
11/16/18
11/16
06:08
11/16/18
06:08
Initiation
Yext initiated  »

Yext initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

PLUS

ePlus

06:07
11/16/18
11/16
06:07
11/16/18
06:07
Initiation
ePlus initiated  »

ePlus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$51.44

-4.51 (-8.06%)

06:07
11/16/18
11/16
06:07
11/16/18
06:07
Downgrade
Energizer rating change  »

Energizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$143.86

-0.39 (-0.27%)

06:06
11/16/18
11/16
06:06
11/16/18
06:06
Periodicals
Zuckerberg says he's still the best person to run Facebook, BI reports »

CEO Mark Zuckerberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

, SHPG

Shire

$178.98

-1.15 (-0.64%)

06:06
11/16/18
11/16
06:06
11/16/18
06:06
Periodicals
Takeda dissident shareholders make final push to stop Shire deal, FT reports »

A dissident group of…

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SHPG

Shire

$178.98

-1.15 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 21

    Dec

SBRA

Sabra Health Care

$19.12

-0.52 (-2.65%)

06:06
11/16/18
11/16
06:06
11/16/18
06:06
Downgrade
Sabra Health Care rating change  »

Sabra Health Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHI

Omega Healthcare

$34.34

-0.13 (-0.38%)

06:05
11/16/18
11/16
06:05
11/16/18
06:05
Upgrade
Omega Healthcare rating change  »

Omega Healthcare upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$25.39

-0.4 (-1.55%)

06:05
11/16/18
11/16
06:05
11/16/18
06:05
Upgrade
DSW rating change  »

DSW upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMX

BioPharmX

$0.18

-0.0032 (-1.77%)

06:05
11/16/18
11/16
06:05
11/16/18
06:05
Hot Stocks
BioPharmX announces NYSE acceptance of plan to regain compliance »

BioPharmX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

06:05
11/16/18
11/16
06:05
11/16/18
06:05
Downgrade
Nvidia rating change  »

Nvidia downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

PBA

Pembina Pipeline

06:04
11/16/18
11/16
06:04
11/16/18
06:04
Upgrade
Pembina Pipeline rating change  »

Pembina Pipeline upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

06:04
11/16/18
11/16
06:04
11/16/18
06:04
Upgrade
EOG Resources rating change  »

EOG Resources upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFI

Armstrong Flooring

$16.66

1.85 (12.49%)

06:03
11/16/18
11/16
06:03
11/16/18
06:03
Upgrade
Armstrong Flooring rating change  »

Armstrong Flooring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$20.52

0.595 (2.99%)

05:59
11/16/18
11/16
05:59
11/16/18
05:59
Upgrade
Lionsgate rating change  »

Lionsgate upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUV

Southwest

$53.23

0.75 (1.43%)

, BA

Boeing

$341.57

-3.06 (-0.89%)

05:59
11/16/18
11/16
05:59
11/16/18
05:59
Periodicals
Southwest replaced 2 flight-control sensors before Lion Air crash, WSJ reports »

During the three weeks…

LUV

Southwest

$53.23

0.75 (1.43%)

BA

Boeing

$341.57

-3.06 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

05:56
11/16/18
11/16
05:56
11/16/18
05:56
Periodicals
Volkswagen board to vote on multi-billion euro investment plan, Reuters reports »

Volkswagen's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

05:51
11/16/18
11/16
05:51
11/16/18
05:51
Recommendations
Nvidia analyst commentary  »

Nvidia 'kitchen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

EQH

AXA Equitable

$20.40

-0.49 (-2.35%)

05:51
11/16/18
11/16
05:51
11/16/18
05:51
Syndicate
AXA Equitable 60M share Secondary priced at $20.25 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 16

    Nov

RWLK

ReWalk Robotics

$0.44

-0.1116 (-20.24%)

05:50
11/16/18
11/16
05:50
11/16/18
05:50
Syndicate
ReWalk Robotics raises $11.6M in a public offering »

ReWalk Robotics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$51.61

0.46 (0.90%)

05:49
11/16/18
11/16
05:49
11/16/18
05:49
Hot Stocks
Sony says has sold 86.1M PS4 units since debut 5 years ago »

Sony says in a blog post…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$143.86

-0.39 (-0.27%)

05:47
11/16/18
11/16
05:47
11/16/18
05:47
Hot Stocks
Facebook COO says allegations she hid info about Russian interference 'untrue' »

Facebook COO Sheryl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.